PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Janssen Pharmaceutica NV, Beerse, Belgium. Electronic address: sdmeyer@its.jnj.com.\', \'Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.\', \'Janssen Pharmaceutica NV, Beerse, Belgium.\', \'Janssen Biopharma Inc, South San Francisco, CA, USA.\', \'Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Center for Infection Research (DZIF), Frankfurt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(20)30392-110.1016/j.ijid.2020.05.085
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 32479865
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Lack of antiviral activity of darunavir against SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32479865>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32479865>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all